Hatteras Venture Partners
Venture capitalResearch Triangle · Seed–Series C
Investment thesis
The firm invests in high-quality science and experienced teams developing breakthrough therapeutics and diagnostics with significant patient impact. They prioritize building excellent companies that reach value inflection points with speed and efficiency, while supporting portfolio companies beyond capital through operational expertise in team recruitment, business development, regulatory strategy, and clinical planning.
Source: firm website, verified Jul 21, 2026.
What they invest in
from 3 of 99 portfolio companiesBiotech ×2Healthtech ×2Medical Devices ×2AI & Machine Learning ×1Digital Health ×1FemTech ×1
HQs:United States×1
Investments · showing 60 of 99
founders shown can be your intro pathDeveloping innovative neuromodulation therapy for large patient populations.
Axonis Therapeutics develops medicines targeting KCC2 to restore inhibition in the brain, with a focus on treating neurological disorders including epilepsy and pain. The company translates discoveries from Boston Children's Hospital, Harvard, and Laval University into first-in-class and best-in-class treatments.
BiotechMedical DevicesBoston, US
Frequently asked questions
- What stage does Hatteras Venture Partners invest at?
- Hatteras Venture Partners invests at the Seed, Series A, Series B, Series C stages.
- What sectors does Hatteras Venture Partners focus on?
- Hatteras Venture Partners focuses on Digital Health, Healthtech, Medical Devices.
- Where is Hatteras Venture Partners located?
- Hatteras Venture Partners is headquartered in Research Triangle, US.
Images
Similar investors
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.
GV is Alphabet's venture capital arm, established in 2009 as Google Ventures. Operating with long time horizons and over $13 billion in assets under management, the firm invests across technology and life sciences sectors from seed to growth stages, supporting 400 active portfolio companies across North America, Europe, and Israel.
Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.